Harmony Biosciences Holdings, Inc. Quarterly Operating Margin in % from Q4 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q2 2024.
  • Harmony Biosciences Holdings, Inc. Operating Margin for the quarter ending June 30, 2024 was 27.1 %, a 7.78% decline year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Operating Margin for 2023 was 33 %, a 20.2% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Operating Margin for 2022 was 27.5 %, a 4.22% decline from 2021.
  • Harmony Biosciences Holdings, Inc. annual Operating Margin for 2021 was 28.7 %, a 169% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 27.1 -2.29 -7.78% Apr 1, 2024 Jun 30, 2024
Q1 2024 33 +4.77 +16.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 33 +5.54 +20.2% Oct 1, 2023 Dec 31, 2023
Q3 2023 36.8 +11.6 +45.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 29.4 -0.86 -2.84% Apr 1, 2023 Jun 30, 2023
Q1 2023 28.2 -2.16 -7.11% Jan 1, 2023 Mar 31, 2023
Q4 2022 27.5 -1.21 -4.22% Oct 1, 2022 Dec 31, 2022
Q3 2022 25.3 +0.19 +0.76% Jul 1, 2022 Sep 30, 2022
Q2 2022 30.3 +6.02 +24.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 30.4 +9.76 +47.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 28.7 +18 +169% Oct 1, 2021 Dec 31, 2021
Q3 2021 25.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 24.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 20.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 10.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.